- Poster presentation
- Open Access
The feasibility of using arterial spin labeling for visualization of non perfused volumes after HIFU treatment in the kidney
© Eschbach et al; licensee BioMed Central Ltd. 2015
- Published: 30 June 2015
- Arterial Spin Label
- Contrast Enhance Image
- Contrast Enhance
- HIFU Intervention
- High Intensity Focus Ultrasound
MR guidance of High Intensity Focused Ultrasound (MFgHIFU) ablation offers the possibility to determine if complete tumor ablation has been established based on imaging the non-perfused volume (NPV). For thermal therapy, contrast enhanced (CE) imaging with a gadolinium-based contrast agent is currently the golden standard to quantify the NPV. A drawback of this method is that gadolinium based intra-vascular contrast agents interfere with HIFU therapy in two ways. First, ablation can release toxic free gadolinium, by long-term decomposition of the encapsulating chelate. Second, it degrades the quality of MR-thermometry. Therefore, even if residual viable tumor tissue is observed with CE-MRI, the treatment cannot be continued. To address this problem for HIFU interventions on the kidney, this study explores other means of perfusion imaging, such as Arterial Spin Labeling (ASL). Petros Martirosan’s group at the University of Tubingen used Flow-sensitive Alternating Inversion Recovery (FAIR) to image perfusion in the kidneys without the use of contrast agents. This in vivo study on a porcine model investigates if ASL potentially allows to perform NPV measurements during therapy and to continue the intervention if incomplete ablation of the target volume is observed.
Image acquisition: An ablation in the renal cortex was performed in an in vivo porcine model. The animal was positioned decubitus right on a Sonalleve HIFU platform (Philips Healthcare, Vantaa, Finland), was under general anesthesia and mechanically ventilated. All scans were performed on a clinical 1.5T MR scanner (Achieva, Philips Healthcare, Best, The Netherlands). 7 treatment cells of 4 mm in diameter each were ablated in a honeycomb-like pattern. To image the NPV without the use of contrast agents, single shot gradient recalled echo-planar imaging of a coronal slice centered at the ablated region was preceded by slice selective inversion and global inversion (in an alternating fashion).
Imaging parameters: in-plane resolution: 3x3 mm2, slice thickness: 5mm, TE/TR: 44/4500 ms, inversion time: 1200 ms, matrix size: 128 x 128, number of dynamics: 20, slice selective inversion slice thickness: 10mm, non-selective inversion slice thickness: 300 mm. For the CE scan, a 3D FFE THRIVE sequence was used with an isotropic resolution of 1.5mm, a TR of 5.4 ms, a TE of 2.6 ms, a flip angle of 10, 2 averages and a reconstruction matrix of 512x512. Data analysis: Matlab (R2013b, The MathWorks, Inc., Natick, MA, USA) was used to realign the individual images, after which a subtraction per dynamic was performed. The subtractions were subsequently summed. Mevislab 2.4 (MeVis Medical Solutions AG, Bremen, Germany) was used to draw contours of NPV.
This work was financially supported by the Center for Translational Molecular Medicine (CTMM), project VOLTA (grant 05T-201).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.